These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 22694853)
21. The utility of selected questionnaires in the assessment of fatigue, depression and health quality in post-sarcoidosis fatigue syndrome. Górski W; Mokros Ł; Kumor-Kisielewska A; Pietras T; Piotrowski WJ Adv Respir Med; 2017; 85(6):313-321. PubMed ID: 29288480 [TBL] [Abstract][Full Text] [Related]
22. The six-minute walk test in sarcoidosis associated pulmonary hypertension: Results from an international registry. Gupta R; Baughman RP; Nathan SD; Wells AU; Kouranos V; Alhamad EH; Culver DA; Barney J; Carmona EM; Cordova FC; Huitema M; Scholand MB; Wijsenbeek M; Ganesh S; Birring SS; Price LC; Wort SJ; Shlobin OA Respir Med; 2022 May; 196():106801. PubMed ID: 35316723 [TBL] [Abstract][Full Text] [Related]
23. CT and physiologic determinants of dyspnea and exercise capacity during the six-minute walk test in mild COPD. Díaz AA; Morales A; Díaz JC; Ramos C; Klaassen J; Saldías F; Aravena C; Díaz R; Lisboa C; Washko GR; Díaz O Respir Med; 2013 Apr; 107(4):570-9. PubMed ID: 23313036 [TBL] [Abstract][Full Text] [Related]
24. Association between calf muscle oxygen saturation with ambulatory function and quality of life in symptomatic patients with peripheral artery disease. Gardner AW; Montgomery PS; Wang M; Shen B J Vasc Surg; 2020 Aug; 72(2):632-642. PubMed ID: 32081480 [TBL] [Abstract][Full Text] [Related]
25. Fatigue in sarcoidosis and idiopathic pulmonary fibrosis: differences in character and severity between diseases. Atkins CP; Gilbert D; Brockwell C; Robinson S; Wilson AM Sarcoidosis Vasc Diffuse Lung Dis; 2016 Aug; 33(2):130-8. PubMed ID: 27537715 [TBL] [Abstract][Full Text] [Related]
26. [Effect of dynamic hyperinflation on exertional dyspnea, exercise performance and quality of life in COPD]. Ozgur ES; Atis S; Kanik A Tuberk Toraks; 2008; 56(3):296-303. PubMed ID: 18932031 [TBL] [Abstract][Full Text] [Related]
27. Predictors of cough-specific and generic quality of life in sarcoidosis patients. Gvozdenovic BS; Mihailovic-Vucinic VV; Vukovic MH; Stjepanovic MI; Buha I; Mihailovic SV; Maric NB Sarcoidosis Vasc Diffuse Lung Dis; 2020; 37(2):158-168. PubMed ID: 33093779 [TBL] [Abstract][Full Text] [Related]
28. The St. George's Respiratory Questionnaire in Pulmonary Sarcoidosis. Lo KH; Donohue J; Judson MA; Wu Y; Barnathan ES; Baughman RP; Lung; 2020 Dec; 198(6):917-924. PubMed ID: 32979072 [TBL] [Abstract][Full Text] [Related]
29. Prognostic value of walk distance, work, oxygen saturation, and dyspnea during 6-minute walk test in COPD patients. Golpe R; Pérez-de-Llano LA; Méndez-Marote L; Veres-Racamonde A Respir Care; 2013 Aug; 58(8):1329-34. PubMed ID: 23322886 [TBL] [Abstract][Full Text] [Related]
30. Assessment of dyspnea in sarcoidosis using the Baseline Dyspnea Index (BDI) and the Transition Dyspnea Index (TDI). Obi ON; Judson MA; Birring SS; Maier LA; Wells AU; Lower EE; Baughman RP Respir Med; 2022 Jan; 191():106436. PubMed ID: 33992496 [TBL] [Abstract][Full Text] [Related]
31. Association between six-minute walk test parameters and the health-related quality of life in patients with pulmonary Mycobacterium avium complex disease. Yagi K; Asakura T; Namkoong H; Suzuki S; Asami T; Okamori S; Kusumoto T; Funatsu Y; Kamata H; Nishimura T; Ishii M; Betsuyaku T; Hasegawa N BMC Pulm Med; 2018 Jul; 18(1):114. PubMed ID: 30005658 [TBL] [Abstract][Full Text] [Related]
32. Paced-walk and step tests to assess exertional dyspnea in COPD. Perrault H; Baril J; Henophy S; Rycroft A; Bourbeau J; Maltais F COPD; 2009 Oct; 6(5):330-9. PubMed ID: 19863362 [TBL] [Abstract][Full Text] [Related]
33. Clinical assessment tests in evaluating patients with chronic obstructive pulmonary disease: A cross-sectional study. Chuang ML; Lin IF; Lee CY Medicine (Baltimore); 2016 Nov; 95(47):e5471. PubMed ID: 27893695 [TBL] [Abstract][Full Text] [Related]
34. The distance-saturation product predicts mortality in idiopathic pulmonary fibrosis. Lettieri CJ; Nathan SD; Browning RF; Barnett SD; Ahmad S; Shorr AF Respir Med; 2006 Oct; 100(10):1734-41. PubMed ID: 16545950 [TBL] [Abstract][Full Text] [Related]
35. The Short- and Long-Term Impact of Pulmonary Rehabilitation in Subjects with Sarcoidosis: A Prospective Study and Review of the Literature. Guber E; Wand O; Epstein Shochet G; Romem A; Shitrit D Respiration; 2021; 100(5):423-431. PubMed ID: 33784708 [TBL] [Abstract][Full Text] [Related]
36. Validation of the Turkish Version of the Sarcoidosis Health Questionnaire: A cross-sectional study. Kavas M; Kaymaz S; Aydoğan Eroglu S; Karasu U; Cobankara V; Boga S Sarcoidosis Vasc Diffuse Lung Dis; 2023 Mar; 40(1):e2023002. PubMed ID: 36975053 [TBL] [Abstract][Full Text] [Related]
37. Physical Activity and Fatigue in Patients with Sarcoidosis. Bahmer T; Watz H; Develaska M; Waschki B; Rabe KF; Magnussen H; Kirsten D; Kirsten AM Respiration; 2018; 95(1):18-26. PubMed ID: 29131111 [TBL] [Abstract][Full Text] [Related]
38. Comparison between the EQ-5D-3L and the SF-6D quality of life (QOL) questionnaires in patients with chronic obstructive pulmonary disease (COPD) undergoing lung volume reduction surgery (LVRS). Thuppal S; Markwell S; Crabtree T; Hazelrigg S Qual Life Res; 2019 Jul; 28(7):1885-1892. PubMed ID: 30707368 [TBL] [Abstract][Full Text] [Related]
39. Submaximal exercise capacity in adolescent and adult patients with cystic fibrosis. Ziegler B; Rovedder PM; Lukrafka JL; Oliveira CL; Menna-Barreto SS; Dalcin Pde T J Bras Pneumol; 2007; 33(3):263-9. PubMed ID: 17906786 [TBL] [Abstract][Full Text] [Related]
40. Application of a new parameter in the 6-minute walk test for manifold analysis of exercise capacity in patients with COPD. Ijiri N; Kanazawa H; Yoshikawa T; Hirata K Int J Chron Obstruct Pulmon Dis; 2014; 9():1235-40. PubMed ID: 25395845 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]